Our RF drug delivery device improves dosing of transdermal drugs. Current trans-dermal drug delivery technologies release the drug over a timeframe of hours to days at a nearly steady rate. But effective dosages vary among patients because stratum corneum thickness vastly varies from person to person. This varying thickness causes absorption rates to also vary from person to person. Our RF delivery system avoids this absorption problem because the stratum corneum is bypassed completely. The drug is applied directly to the normal living cells which more readily absorb the drug, concurrently allowing absorption of a much wider range of drug molecule variants (size, pH, and solubility) at a consistent rate. Modulating the RF signal, and thus modulating the rate of drug application, allows for much more flexibility in dosage scheduling.
Competitive Advantages:
Desired Partnerships: